eNauka - pregled

Pregled prema Autor Mistry, Pramod K

Prikaz rezultata 1 do 4 od 4
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2013A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9 months of treatmentMistry, Pramod K; Lukina, Elena; Ben, Dridi Marie-Francoise; Amato, Dominick J; Baris, Hagit; Dasouki, Majed; Ghosn, Marwan; Mehta, Atul; Packman, Seymour; Pastores, Gregory M;
Petakov, Milan S; Peterschmitt, Judith M;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final resultsMistry, Pramod K; ...; Petakov, Milan S; ...; (broj, koautora 18)Naučni članak
21aM21a - Rad u međ. časopisu izuzetnih vrednosti
2020Individual patient responses to eliglustat in treatment-naive adults with Gaucher disease type 1: Final data from the phase 3 ENGAGE trialMistry, Pramod K; ...; Petakov, Milan S; ...; (broj, koautora 18)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2017Long-term results of ENGAGE: a phase 3, randomized, double blind, placebo-controlled, multi center study investigating the efficacy and safety of eliglustat in adults with type 1 Gaucher diseaseMistry, Pramod K; ...; Petakov, Milan S; ...; (broj, koautora 18)Konferencijski rad
Mp kategorija će biti prikazana naknadno.